CAR T Cell Therapy Targeting IGHV4-34 B Cell Malignancies
Contributed to the development of CART4-34, a precision CAR T cell therapy targeting IGHV4-34+ B cell malignancies, published in Science Translational Medicine (2026). My work focused on solving a transduction efficiency bottleneck in CAR T cell manufacturing.